Subcutaneous injection
Rocheās subcutaneous Tecentriq faces FDA setback due to manufacturing updates
Anika Sharma
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...
Promising Phase III Results: OCREVUS (Ocrelizumab) Subcutaneous Injection Offers Convenient and Efficient Treatment for Multiple Sclerosis
SG Tylor
Source – Roche On 13 July Roche announced positive results from the Phase III OCARINA II trial, which investigated the ...
